UK - AXA Investment Managers - a unit of AXA Group - has enhanced its equity research team with the addition of two new analysts.
Jan Keuppans joins the technology team from AXA IM’s operation in The Netherlands where he has worked for the past three years. He will be responsible for software and IT companies.
Keuppans previously worked for Corluy, a Belgian specialist securities house where he managed global equity portfolios. He also has experience in managing pan-European equity portfolios.
Chris Donnellan joins the pharmaceutical team from Datamonitor, the market research company, where he led a team conducting market research into key pharmaceutical products.
His earlier medical research career was gained at SmithKline Beecham.
By Madhu Kalia
Most respondents in this week's Pensions Buzz do not think businesses should be able suspend AE contributions if in financial distress.
Former BHS owner Dominic Chappell has lost the appeal against his section 72 conviction and sentence for failing to hand over information to The Pensions Regulator (TPR).
This week's top stories include Marsh and McLennan Companies agreeing to buy JLT, and the home secretary calling for AE to be scrapped in a no-deal Brexit scenario.
Lesley Titcomb says the watchdog wants closer interactions with pension funds to spot problems sooner and act before having to use its more stringent powers